ADUS · Addus Homecare Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $363.61M | - | $362.30M | $349.44M | $337.71M | - | $289.79M | $286.92M | $280.75M | - |
| Cost of Revenue | $247.74M | - | $245.59M | $235.57M | $230.03M | - | $197.58M | $193.76M | $192.57M | - |
| Gross Profit | $115.87M | - | $116.72M | $113.88M | $107.68M | - | $92.20M | $93.16M | $88.18M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $77.77M | - | $79.37M | $77.08M | $73.22M | - | $62.80M | $63.58M | $61.06M | - |
| Total Operating Expenses | $81.80M | - | $83.78M | $80.99M | $77.16M | - | $66.25M | $66.98M | $64.53M | - |
| D&A | $4.03M | - | $4.41M | $3.91M | $3.94M | - | $3.45M | $3.40M | $3.47M | - |
| Operating Income | $34.07M | - | $32.94M | $32.89M | $30.51M | - | $25.95M | $26.18M | $23.64M | - |
| Interest Expense | $2.15M | - | $3.34M | $3.52M | $2.76M | - | $573.0K | $2.11M | $2.76M | - |
| Income Tax | $7.36M | - | $7.51M | $7.89M | $5.77M | - | $7.13M | $6.46M | $5.48M | - |
| Net Income | $25.07M | - | $22.85M | $22.05M | $21.23M | - | $20.16M | $18.08M | $15.83M | - |
| EPS - Basic | $1.38 | - | $1.26 | $1.22 | $1.18 | - | $1.13 | $1.12 | $0.99 | - |
| EPS - Diluted | $1.36 | - | $1.24 | $1.20 | $1.16 | - | $1.10 | $1.10 | $0.97 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $103.06M | $81.62M | $101.92M | $98.91M | $96.95M | $98.91M | $222.85M | $173.31M | $76.72M | $64.79M |
| Accounts Receivable | $144.82M | $151.69M | $134.05M | $140.10M | $134.61M | $122.88M | $96.60M | $109.19M | $104.73M | $115.50M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $14.04M | $16.83M | $16.68M | $15.69M | $27.97M | $27.18M | $27.73M | $20.19M | $22.02M | $26.18M |
| Current Assets | $272.88M | $269.49M | $260.66M | $263.05M | $257.83M | $260.38M | $332.81M | $294.99M | $191.85M | $200.00M |
| Total Assets | $1.44B | $1.44B | $1.42B | $1.41B | $1.41B | $1.41B | $1.15B | $1.12B | $1.01B | $1.02B |
| Current Liabilities | $149.47M | $149.49M | $156.80M | $151.38M | $147.94M | $155.87M | $157.82M | $147.53M | $141.59M | $145.12M |
| Long-term Debt | $91.27M | $120.96M | $150.64M | $169.06M | $198.74M | $218.44M | - | - | $99.35M | $124.13M |
| Total Liabilities | $319.54M | $352.00M | $372.96M | $387.08M | $412.20M | $442.14M | $205.27M | $194.90M | $288.86M | $317.73M |
| Stockholders' Equity | $1.12B | $1.09B | $1.05B | $1.02B | $995.38M | $970.49M | $947.63M | $921.65M | $725.14M | $706.69M |
| Retained Earnings | $497.41M | $472.34M | $442.56M | $419.71M | $397.66M | $376.43M | $356.90M | $336.74M | $318.66M | $302.83M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $52.37M | - | - | - | $18.95M | - | - | - | $38.68M | - |
| Investing Cash Flow | ($1.69M) | - | - | - | ($1.38M) | - | - | - | ($1.75M) | - |
| Financing Cash Flow | ($29.23M) | - | - | - | ($19.53M) | - | - | - | ($25.00M) | - |
| CapEx | $1.71M | - | - | - | $1.88M | - | - | - | $1.35M | - |
| Free Cash Flow | $50.65M | - | - | - | $17.07M | - | - | - | $37.33M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 31.9% | - | 32.2% | 32.6% | 31.9% | - | 31.8% | 32.5% | 31.4% | - |
| Operating margin | 9.4% | - | 9.1% | 9.4% | 9.0% | - | 9.0% | 9.1% | 8.4% | - |
| EBITDA margin | 10.5% | - | 10.3% | 10.5% | 10.2% | - | 10.1% | 10.3% | 9.7% | - |
| Net margin | 6.9% | - | 6.3% | 6.3% | 6.3% | - | 7.0% | 6.3% | 5.6% | - |
| Free cash flow margin | 13.9% | - | - | - | 5.1% | - | - | - | 13.3% | - |
| FCF / Net income | 2.02 | - | - | - | 0.80 | - | - | - | 2.36 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 21.4% | - | 21.9% | 22.1% | 21.7% | - | 21.7% | 22.2% | 21.8% | - |
| Effective tax rate | 22.7% | - | 24.7% | 26.4% | 21.4% | - | 26.1% | 26.3% | 25.7% | - |
| Return on assets | 1.7% | - | 1.6% | 1.6% | 1.5% | - | 1.7% | 1.6% | 1.6% | - |
| Return on equity | 2.2% | - | 2.2% | 2.2% | 2.1% | - | 2.1% | 2.0% | 2.2% | - |
| Return on invested capital | 2.2% | - | 2.1% | 2.0% | 2.0% | - | - | - | 2.1% | - |
| Liquidity | ||||||||||
| Current ratio | 1.83 | 1.80 | 1.66 | 1.74 | 1.74 | 1.67 | 2.11 | 2.00 | 1.35 | 1.38 |
| Quick ratio | 1.83 | 1.80 | 1.66 | 1.74 | 1.74 | 1.67 | 2.11 | 2.00 | 1.35 | 1.38 |
| Cash ratio | 0.69 | 0.55 | 0.65 | 0.65 | 0.66 | 0.63 | 1.41 | 1.17 | 0.54 | 0.45 |
| Leverage | ||||||||||
| Debt / Equity | 0.08 | 0.11 | 0.14 | 0.17 | 0.20 | 0.23 | - | - | 0.14 | 0.18 |
| Debt / Assets | 0.06 | 0.08 | 0.11 | 0.12 | 0.14 | 0.15 | - | - | 0.10 | 0.12 |
| Debt / EBITDA | 2.40 | - | 4.03 | 4.59 | 5.77 | - | - | - | 3.66 | - |
| Interest coverage | 15.8x | - | 9.9x | 9.3x | 11.1x | - | 45.3x | 12.4x | 8.6x | - |
| Equity multiplier | 1.29 | 1.32 | 1.36 | 1.38 | 1.41 | 1.46 | 1.22 | 1.21 | 1.40 | 1.45 |
| Liabilities / Assets | 0.22 | 0.24 | 0.26 | 0.27 | 0.29 | 0.31 | 0.18 | 0.17 | 0.28 | 0.31 |
| Efficiency | ||||||||||
| Asset turnover | 0.25 | - | 0.25 | 0.25 | 0.24 | - | 0.25 | 0.26 | 0.28 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 145d | - | 135d | 146d | 145d | - | 122d | 139d | 136d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 21d | - | 25d | 24d | 44d | - | 51d | 38d | 42d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 68.9x | - | 95.2x | 96.0x | 85.2x | - | 120.9x | 105.6x | 106.5x | - |
| P / B | 1.6x | - | 2.1x | 2.1x | 1.8x | - | 2.6x | 2.1x | 2.3x | - |
| P / S | 4.8x | - | 6.0x | 6.0x | 5.4x | - | 8.4x | 6.7x | 6.0x | - |
| EV / EBITDA | 45.1x | - | 59.4x | 59.3x | 55.5x | - | 75.0x | 58.9x | 63.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 7.7% | - | 25.0% | 21.8% | 20.3% | - | 7.0% | 10.4% | 11.6% | - |
| Revenue CAGR (3y) | 13.1% | - | 14.6% | 13.8% | 14.2% | - | 10.2% | 9.6% | 11.0% | - |
| Revenue CAGR (5y) | 12.1% | - | 13.3% | 13.6% | 12.2% | - | 11.3% | 13.9% | 15.1% | - |
| Gross profit growth (YoY) | 7.6% | - | 26.6% | 22.2% | 22.1% | - | 6.3% | 13.2% | 12.4% | - |
| Operating income growth (YoY) | 11.7% | - | 26.9% | 25.6% | 29.1% | - | 13.6% | 21.6% | 27.1% | - |
| Net income growth (YoY) | 18.1% | - | 13.3% | 22.0% | 34.1% | - | 30.8% | 21.7% | 24.9% | - |
| EPS growth (YoY) | 17.2% | - | 12.7% | 9.1% | 19.6% | - | 15.8% | 20.9% | 24.4% | - |
| EPS CAGR (3y) | 20.4% | - | 20.4% | 19.7% | 29.8% | - | 15.2% | 15.2% | 20.8% | - |
| EPS CAGR (5y) | 19.8% | - | 16.8% | 22.8% | 16.5% | - | 26.5% | 21.8% | 21.9% | - |
| FCF growth (YoY) | 196.8% | - | - | - | -54.3% | - | - | - | 107.1% | - |
| FCF CAGR (5y) | - | - | - | - | -0.7% | - | - | - | - | - |
| Book value growth (YoY) | 12.1% | 11.8% | 10.8% | 10.9% | 37.3% | 37.3% | 38.5% | 38.3% | 11.8% | 11.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.27B totalPersonal Care$1.09B · 48.0%
Personal Care Segment$553.48M · 24.4%
Hospice$262.54M · 11.6%
Hospice Segment$244.34M · 10.8%
Home Health$70.77M · 3.1%
Home Health Segment$47.70M · 2.1%
Geographic
$1.22B totalIL$458.83M · 37.6%
All Other States$295.09M · 24.2%
TX$216.71M · 17.8%
NM$118.59M · 9.7%
OH$101.83M · 8.4%
TN$28.21M · 2.3%
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing Addus HomeCare Corp against the 5 most active filers in the same SIC group.